Engineered insulin secretion from neuroendocrine cells isolated from human thyroid

World Journal of Surgery

Volumn 38, Issue 6, 2014, Pages 1251-1261

  Thulé, Peter M ^a,b   Jia, Dingwu ^a   Safley, Susan ^b   Gordon, Kereen ^b   Barber, Graham ^b   Yi, Hong ^c   Nalli, Soumya ^a   Onderci, Muhittin ^d   Sharma, Jyotirmay ^b   Shires, John ^b   Weber, Collin J ^b  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d ADIYAMAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 6; INSULIN; MESSENGER RNA;

BIOENGINEERING; CELL CULTURE; CYTOLOGY; DIABETES MELLITUS, TYPE 1; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METABOLISM; NEUROSECRETORY CELL; PANCREAS ISLET BETA CELL; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; SECRETION (PROCESS); SENSITIVITY AND SPECIFICITY; THYROID GLAND; TRANSMISSION ELECTRON MICROSCOPY;

BIOENGINEERING; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HEPATOCYTE NUCLEAR FACTOR 6; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICROSCOPY, ELECTRON, TRANSMISSION; NEUROENDOCRINE CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; THYROID GLAND;

EID: 84902149899     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-014-2457-7     Document Type: Article

References (50)

1. Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ (2010) All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry. Diabetes Care 33(12):2573-2579. doi: 10.2337/dc10-1170
2. Pogach L, Aron D (2010) Balancing hypoglycemia and glycemic control: a public health approach for insulin safety. JAMA 303(20):2076-2077. doi: 10.1001/jama.2010.655
3. Awoniyi O, Rehman R, Dagogo-Jack S (2013) Hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention. Curr Diab Rep 13:669-678. doi: 10.1007/s11892-013-0411-y
4. Shapiro J, Lakey J, Ryan E, Korbutt G, Toth E, Warnock G et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238
5. Shapiro AMJ, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP et al (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355(13):1318-1330. doi: 10.1056/NEJMoa061267
6. Rother KI, Harlan DM (2004) Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 114(7):877-883. doi: 10.1172/JCI23235
7. Harlan DM, Kenyon NS, Korsgren O, Roep BO (2009) Current advances and travails in islet transplantation. Diabetes 58(10):2175-2184. doi: 10.2337/db09-0476
8. Yechoor V, Liu V, Espiritu C, Paul A, Oka K, Kojima H et al (2009) Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev Cell 16(3):358-373
9. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455(7213):627-632
10. Okura H, Komoda H, Fumimoto Y, Lee C-M, Nishida T, Sawa Y et al (2009) Transdifferentiation of human adipose tissue-derived stromal cells into insulin-producing clusters. J Artif Organs 12(2):123-130
11. Hickey RD, Galivo F, Schug J, Brehm MA, Haft A, Wang Y et al (2013) Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming. Stem Cell Res 11(1):503-515. doi: 10.1016/j.scr.2013.02.005
12. De Kort H, de Koning EJ, Rabelink TJ, Bruijn JA, Bajema IM (2011) Islet transplantation in type 1 diabetes. BMJ. doi: 10.1136/bmj.d217
13. Ozer K, Yechoor V, Buras E, Liu V, Chan L (2010) Gene therapy for type 1 diabetes: a combinatorial approach using neurogenein-3-interleukin-10 hepatic gene transfer reverses diabetes in overtly diabetic NOD mice. Endocr Rev 31(Supp1):P2-P114
14. Thule PM, Liu J, Phillips LS (2000) Glucose regulated production of human insulin in rat hepatocytes. Gene Ther 7(3):205-214
15. Olson D, Paveglio S, Huey P, Porter M, Thule P (2003) Glucose responsive hepatic insulin gene therapy of spontaneously diabetic BB/Wor rats. Hum Gene Ther 14(15):1401-1413
16. Nagamatsu S, Nakamichi Y, Ohara-Imaizumi M, Ozawa S, Katahira H, Watanabe T et al (2001) Adenovirus-mediated preproinsulin gene transfer into adipose tissues ameliorates hyperglycemia in obese diabetic KKA(y) mice. FEBS Lett 509(1):106-110
17. Brion C, Miller SG, Moore HP (1992) Regulated and constitutive secretion: differential effects of protein synthesis arrest on transport of glycosaminoglycan chains to the two secretory pathways. J Biol Chem 267(3):1477-1483
18. Lipes MA, Cooper EM, Skelly R, Rhodes CJ, Boschetti E, Weir GC et al (1996) Insulin-secreting non-islet cells are resistant to autoimmune destruction. Proc Natl Acad Sci USA 93(16):8595-8600
19. Lu YC, Sternini C, Rozengurt E, Zhukova E (2005) Release of transgenic human insulin from gastric G cells: a novel approach for the amelioration of diabetes. Endocrinology 146(6):2610-2619. doi: 10.1210/en.2004-1109
20. Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, Lansdorp PM et al (1998) Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA 95(25):14723-14728
21. Merten OW (2004) State-of-the-art of the production of retroviral vectors. J Gene Med 6(S1):S105-S124. doi: 10.1002/jgm.499
22. Groskreutz DJ, Sliwkowski MX, Gorman CM (1994) Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J Biol Chem 269:6241-6245
23. Klages N, Zufferey R, Trono D (2000) A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol Ther 2(2):170-176
24. McCarty DM, Fu H, Monahan PE, Toulson CE, Naik P, Samulski RJ et al (2003) Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther 10(26):2112-2118
25. Haberman R, Kroner-Lux G, Samulski R (1999) Production of adeno-associated viral vectors. In: Dracopoli N, Haines J, Korf B, Moir D, Mortan C, Seidman C et al (eds) Current protocols in human genetics, vol Suppl 23. Wiley, New York, pp 12.9.1-12.9.6
26. Choi VW, Asokan A, Haberman RA, Samulski RJ (2007) Production of recombinant adeno-associated viral vectors. Curr Protoc Hum Genet. Chap 12, Unit 12.9. doi 10.1002/0471142905.hg1209s53
27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402-408. doi: 10.1006/meth.2001.1262
28. Montuenga LM, Guembe L, Burrell MA, Bodegas ME, Calvo A, Sola JJ et al (2003) The diffuse endocrine system: from embryogenesis to carcinogenesis. Prog Histochem Cytochem 38(2):155-272
29. Di Palma T, D'Andrea B, Liguori GL, Liguoro A, de Cristofaro T, Del Prete D et al (2009) TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation. Exp Cell Res 315(2):162-175. doi: 10.1016/j.yexcr.2008.10.016
30. Afink GB, Veenboer G, de Randamie J, Keijser R, Meischl C, Niessen H et al (2010) Initial characterization of C16orf89, a novel thyroid-specific gene. Thyroid 20(7):811-821. doi: 10.1089/thy.2009.0366
31. Fernández-Santos JM, Morillo-Bernal J, García-Marín R, Utrilla JC, Martín-Lacave I (2012) Paracrine regulation of thyroid-hormone synthesis by C cells. In: Agrawal NK (ed) Thyroid hormone. Rijeka, InTech
32. Ernfors P, Wetmore C, Olson L, Persson H (1990) Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron 5(4):511-526
33. Tongiorgi E (2008) Activity-dependent expression of brain-derived neurotrophic factor in dendrites: facts and open questions. Neurosci Res 61(4):335-346. doi: 10.1016/j.neures.2008.04.013
34. Katsetos CD, Legido A, Perentes E, Mork SJ (2003) Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology. J Child Neurol 18(12):851-866 discussion 867
35. Michalczyk K, Ziman M (2005) Nestin structure and predicted function in cellular cytoskeletal organisation. Histol Histopathol 20(2):665-671
36. Leja J, Essaghir A, Essand M, Wester K, Oberg K, Totterman TH et al (2009) Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas. Mod Pathol 22(2):261-272. doi: 10.1038/modpathol. 2008.174
37. Roll S, Seul J, Paulsson M, Hartmann U (2006) Testican-1 is dispensable for mouse development. Matrix Biol 25(6):373-381. doi: 10.1016/j.matbio.2006.05. 004
38. Salton SR, Ferri GL, Hahm S, Snyder SE, Wilson AJ, Possenti R et al (2000) VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance. Front Neuroendocrinol 21(3):199-219. doi: 10.1006/frne.2000.0199
39. Kim KH, Seong B (2001) Peptide amidation: production of peptide hormones in vivo andin vitro. Biotechnol Bioprocess Eng 6(4):244-251. doi: 10.1007/BF02931985
40. Braas KM, Harakall SA, Ouafik L, Eipper BA, May V (1992) Expression of peptidylglycine alpha-amidating monooxygenase: an in situ hybridization and immunocytochemical study. Endocrinology 130(5):2778-2788. doi: 10.1210/en.130.5.2778
41. Liu KP, Russo AF, Hsiung SC, Adlersberg M, Franke TF, Gershon MD et al (2003) Calcium receptor-induced serotonin secretion by parafollicular cells: role of phosphatidylinositol 3-kinase-dependent signal transduction pathways. J Neurosci 23(6):2049-2057
42. Barasch JM, Tamir H, Nunez EA, Gershon MD (1987) Serotonin-storing secretory granules from thyroid parafollicular cells. J Neurosci 7(12):4017-4033
43. Clark MS, Lanigan TM, Page NM, Russo AF (1995) Induction of a serotonergic and neuronal phenotype in thyroid C-cells. J Neurosci 15:6167-6178
44. Soyer J, Flasse L, Raffelsberger W, Beucher A, Orvain C, Peers B et al (2010) Rfx6 is an Ngn3-dependent winged helix transcription factor required for pancreatic islet cell development. Development 137(2):203-212. doi: 10.1242/dev.041673
45. Rukstalis JM, Habener JF (2009) Neurogenin3: a master regulator of pancreatic islet differentiation and regeneration. Islets 1(3):177-184. doi: 10.4161/isl.1.3.9877
46. Limbert C, Path G, Ebert R, Rothhammer V, Kassem M, Jakob F et al (2011) PDX1- and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages. Cytotherapy 13(7):802-813. doi: 10.3109/14653249.2011.571248
47. Wang K, Holterman AX (2012) Pathophysiologic role of hepatocyte nuclear factor 6. Cell Signal 24(1):9-16. doi: 10.1016/j.cellsig.2011.08.009
48. Im SS, Kim SY, Kim HI, Ahn YH (2006) Transcriptional regulation of glucose sensors in pancreatic beta cells and liver. Curr Diab Rev 2(1):11-18
49. Jensen RT, Battey JF, Spindel ER, Benya RV (2008) International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60(1):1-42. doi: 10.1124/pr.107.07108
50. Ahren B (2000) Autonomic regulation of islet hormone secretion: implications for health and disease. Diabetologia 43(4):393-410